Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Plos One|April 27, 2018
Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus VianniaCarlos Franco-Muñoz, Merab Manjarrés-Estremor, Clemencia Ovalle-Bracho
Biomedica : Revista Del Instituto Nacional De Salud|November 5, 2020
SARS-CoV-2 sequencing: The technological initiative to strengthen early warning systems for public health emergencies in Latin America and the CaribbeanDiego A Álvarez-Díaz, Katherine Laiton-Donato, Carlos Franco-Muñoz, et al.
Parasitology|October 8, 2015
Functional evaluation of gene silencing on macrophages derived from U937 cells using interference RNA (shRNA) in a model of macrophages infected with Leishmania (Viannia) braziliensisClemencia Ovalle-Bracho, Diana A Londoño-Barbosa, Carlos Franco-Muñoz, et al.
Plos One|June 9, 2015
Changes in Macrophage Gene Expression Associated with Leishmania (Viannia) braziliensis InfectionClemencia Ovalle-Bracho, Carlos Franco-Muñoz, Diana Londoño-Barbosa, et al.
Vaccines|November 21, 2020
COVID-19 Infection Detection and Prevention by SARS-CoV-2 Active Antigens: A Synthetic Vaccine ApproachJosé Manuel Lozano, Luz Mary Salazar, Ángela Torres, et al.
International Journal of Molecular Sciences|October 16, 2025
From Bioinformatics Analysis to Recombinant Expression: Advancing Public Health with <i>Taenia solium</i> ProteinsJuana Muñoz, María Camila Jurado Guacaneme, Clemencia Ovalle-Bracho, et al.
Biomedica : Revista Del Instituto Nacional De Salud|November 5, 2020
Isolation and characterization of an early SARS-CoV-2 isolate from the 2020 epidemic in Medellín, ColombiaFrancisco J Díaz, Wbeimar Aguilar-Jiménez, Lizdany Flórez-Álvarez, et al.
Biomedica : Revista Del Instituto Nacional De Salud|September 19, 2022
Monkeypox virus genome sequence from an imported human case in ColombiaKatherine Laiton-Donato, Diego A Álvarez-Díaz, Carlos Franco-Muñoz, et al.
Virus Research|November 15, 2021
Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineageDiego A Álvarez-Díaz, Katherine Laiton-Donato, Orlando Alfredo Torres-García, et al.
Vaccines|December 23, 2022
Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in ColombiaDiego A Álvarez-Díaz, Ana Luisa Muñoz, María T Herrera-Sepúlveda, et al.
Pageof 3